Immunotherapy

Radiation prior to combination immunotherapy did not influence clinical outcomes among patients with metastatic renal cell carcinoma and bone metastases, according to study results presented at International Kidney Cancer Symposium.

The Society for Immunotherapy of Cancer announced the inaugural class of Fellows of the Academy of Immuno-Oncology.

In a recent article, Nicholas J. Petrelli, MD, FACS, associate editor of surgical oncology for HemOnc Today, reflected on the power of optimism and progress in cancer care that has increased survival and quality of life among patients.

In this video, Upal Basu Roy, PhD, MPH, spoke with Healio about “fantastic presentations” from this year’s International Association for the Study of Lung Cancer World Conference on Lung Cancer.

The world of cancer cell therapy continues to evolve, and the next breakthrough may include T cells genetically modified to include T-cell receptors that recognize a wider array of tumor-associated antigens.

The world of cancer cell therapy continues to evolve, and the next breakthrough may include T cells genetically modified to include T-cell receptors that recognize a wider array of tumor-associated antigens.

As we enter the fall season, baseball fans are excited for the World Series.

The mRNA-1273 COVID-19 vaccine appeared safe and effective during treatment with immunotherapy and chemotherapy among patients with solid tumor cancers, according to results of the VOICE trial presented during the virtual ESMO Congress 2021.

Patients with resected stage IIB or stage IIC melanoma who received adjuvant pembrolizumab demonstrated a 35% reduction in risk for disease recurrence or death, according to results of the randomized phase 3 KEYNOTE-716 study.

Older patients with late-stage non-small cell lung cancer appeared to benefit from immunotherapy, according to results presented at International Association for the Study of Lung Cancer World Conference on Lung Cancer.